Globus Medical to buy NuVasive in deal valued at $3.1 billion (updated)

NuVasive

09/02/2023 12:17

(Adds deal details)
       Feb 9 (Reuters) - Globus Medical Inc  GMED.N  said on
Thursday it was acquiring spine-related medical device maker
NuVasive Inc  NUVA.O  in an all-stock deal valued at $3.1
billion. 
    NuVasive shareholders will receive 0.75 of Globus' share, 
which implies a stock price of $57.72 for NuVasive, representing
a premium of about 26% to its last close.
        Following the close of the transaction, NuVasive
shareholders will own about 28% of the combined company, and
Globus Medical shareholders will own approximately 72%.
  
 (Reporting by Raghav Mahobe in Bengaluru; Editing by Maju
Samuel)
 ((Raghav.Mahobe@thomsonreuters.com;))